IMATINIB

imatinib 600 mg tablet, 30

IMATINIB (12928K)

imatinib 600 mg tablet, 30
12928K
Body System:
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 17829)

Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Continuing treatment

Restriction (Streamlined authority code: 17830)

Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 30 # of repeats: 2 DPMQ: $560.42 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Imatab